BioPharma Drive: Drug Pricing
JULY 31, 2023
According to the company, FDA officials have signaled openness to using a surrogate endpoint for assessing accelerated approval of a treatment for limb-girdle muscular dystrophy.
Drugs.com
AUGUST 4, 2023
FRIDAY, Aug. 4, 2023 -- Los Angeles county is seeing more cases of flea-borne typhus, with 171 cases and three deaths reported in 2022, health officials reported Thursday. That's a big rise, they noted: Since 2010, when only 31 cases of typhus were.
Perficient: Drug Development
AUGUST 4, 2023
In today’s rapidly advancing technology landscape, businesses face a profound revolution in operations, customer interactions, and innovative endeavors. Partnering with the right digital transformation service provider is vital to thrive in this digital age. A proven track record of guiding businesses through digital complexities is crucial for unlocking their full potential, driving efficiency, and ensuring exceptional customer experiences, leading to long-term success.
Translation
AUGUST 2, 2023
People say we need to “save the planet,” but the planet is going to be just fine. In a million years, this will be a lush green planet, teeming with life—the only question is whether humans will be here to enjoy it. Rather than saving the planet, our mission is to save ourselves by saving the planet. With the incredible power of exponential technologies, new business models, and the vast resources at our disposal, we have the potential to leave a positive impact for not only current generations,
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Antidote
AUGUST 2, 2023
At Antidote, our mission is to connect patients with clinical trials is only possible when we understand the individuals that make up the patient population. One way we are able to gain this understanding is by providing our clinical trial search tool, Antidote Match , at no cost to over 300 organizations that we partner with.
Drugs.com
AUGUST 3, 2023
THURSDAY, Aug. 3, 2023 -- A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk of severe stomach problems. The lawsuit seeks “very.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
BioPharma Drive: Drug Pricing
AUGUST 3, 2023
One patient received its Duchenne gene therapy, Elevidys, this week and a handful more could follow shortly, surprising some analysts and raising near-term sales expectations.
Drug Target Review
JULY 31, 2023
Dear Readers, I am thrilled to announce the launch of our new series, “Beyond the Lab,” which promises to deliver high-level insights commissioned exclusively by Drug Target Review magazine. Our inaugural report is a groundbreaking exploration of the remarkable advancements in cell and gene therapy that are revolutionising the field of drug discovery.
Drugs.com
AUGUST 3, 2023
THURSDAY, Aug. 3, 2023 -- While both the Moderna and Pfizer COVID-19 vaccines are considered safe and highly effective, new research finds the Moderna shot has been the safest and most effective for seniors. “The results of this study can help.
Perficient: Drug Development
AUGUST 1, 2023
Most senior leadership today is at least partially focused on ensuring that their organizations culture, productivity, and employee engagement are keeping pace with the competition. Microsoft Viva has emerged as a cost-effective and tightly-integrated suite of tools that allows companies to provide pointed solutions for many employee experience challenges.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
KIF1A
JULY 29, 2023
#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A in New York: The 2023 KAND Family & Scientific Engagement Conference We won’t be posting next Saturday, but not for a lack of science!
Drug Target Review
JULY 31, 2023
Can you tell us about your journey in the field of STEM and the challenges you encountered along the way? I started out as an art history major at Bryn Mawr College, a women’s college in Pennsylvania, US. I was ‘pre-med’ and got really interested in the science and especially the integration of chemistry and art. Art is made of chemistry (as paintings are made from pigments, oils, and other materials) and we were interested in what about the chemistry made a work of art change over time.
Drugs.com
AUGUST 3, 2023
THURSDAY, Aug. 3, 2023 -- Yoga is known for its benefits to both the mind and body. And a gentle form of yoga may be an ideal early intervention technique for older women at risk of Alzheimer's disease, new research suggests. In a small study.
FDA Law Blog: Biosimilars
JULY 31, 2023
By Larry K. Houck — President Barack Obama signed the Comprehensive Addiction and Recovery Act of 2016 (“CARA”) intended to reverse serious prescription drug abuse trend in the United States on July 22, 2016. CARA amended the Controlled Substances Act (“CSA”) to enable physicians or patients to request pharmacists to partially fill prescriptions for schedule II substances including opioids and to allow remaining quantities to be filled up to 30 days after issuance of the prescription (up to 72
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
ProRelix Research
AUGUST 3, 2023
Although the United States Food and Drug Administration (FDA) has always supported and advocated the idea of decentralized trials, the real adoption and application of decentralized aspects in trials has […] The post FDA Guidance on Advancement of Decentralized Clinical Trials appeared first on ProRelix Research.
Antidote
AUGUST 4, 2023
One of the key challenges in medical research is successful patient enrollment. It is not uncommon for trials to fall behind schedule due to low patient engagement — but by creating a recruitment and enrollment strategy centered on patient-centricity , more successful research processes can be made possible. Below, we are exploring some of the top ways to do just that.
Drugs.com
AUGUST 3, 2023
THURSDAY, Aug. 3, 2023 -- J.D. Butler was planning a future with his girlfriend at his favorite New York City restaurant when that future came to a sudden, crushing halt. “They were planning on when she was moving in and arranging floor plans on.
Practical Cheminformatics
AUGUST 3, 2023
Most papers describing new methods for machine learning (ML) in drug discovery report some sort of benchmark comparing their algorithm and/or molecular representation with the current state of the art. In the past, I’ve written extensively about statistics and how methods should be compared. In this post, I’d like to focus instead on the datasets we use to benchmark and compare methods.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
SCIENMAG: Medicine & Health
AUGUST 2, 2023
“Our work demonstrates exceptional molecule recognition and separation performance by deliberately organizing the pore geometry, structural flexibility, and molecular-level binding sites within a porous coordination polymer (PCP),” says chemist Susumu Kitagawa, leader of the research team at Kyoto University’s Institute for Integrated Cell-Material Sciences.
BioPharma Drive: Drug Pricing
AUGUST 4, 2023
The surprise rejection of a high-dose form of Eylea could be resolved earlier than anticipated. But some of the company’s pipeline projects have stumbled.
Drugs.com
AUGUST 4, 2023
FRIDAY, Aug. 4, 2023 -- The trauma and unhappy family dynamics of childhood may follow kids into old age, affecting both their mind and body, according to new research. “We looked at self-reported disability, as well as objectively measured.
Drug Patent Watch
AUGUST 2, 2023
In the world of prescription drugs, brand-name manufacturers have employed various strategies to maintain revenue streams in the face of generic competition. One such strategy is the use of “authorized… The post Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study appeared first on DrugPatentWatch - Make Better Decisions.
SCIENMAG: Medicine & Health
AUGUST 4, 2023
A multidisciplinary study led by scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) presents a new method for assessing the structural and electrophysiological changes, called atrial remodeling, produced in the heart of patients with atrial fibrillation, one of the most frequent forms of cardiac arrhythmia.
BioPharma Drive: Drug Pricing
AUGUST 2, 2023
Intergalactic, a developer of non-viral gene therapies built by ex-Biogen executive Michael Ehlers, is folding less than two years after its launch.
Drugs.com
AUGUST 2, 2023
WEDNESDAY, Aug. 2, 2023 -- Artificial intelligence (AI) programs can safely be used to help radiologists review mammogram images and detect breast cancers, early results from an ongoing clinical trial show. A single radiologist aided by AI wound up.
Drug Channels
AUGUST 4, 2023
Today’s guest post comes from Jonas Boli, Chief Product Officer at Phil, Inc. Jonas describes the challenges patients face when accessing specialty therapies and explains how patient abandonment affects manufacturers over time. He argues that an effective telemedicine program can help patients via an end-to-end digital experience. To learn more, register for Phil’s free webinar on August 29th at 2 p.m.
SCIENMAG: Medicine & Health
AUGUST 1, 2023
ATLANTA, August 1, 2023 – A new study from researchers at the American Cancer Society (ACS) found monthly adult cancer diagnoses decreased by half in April 2020 during the COVID-19 pandemic in the United States. The largest decrease was for stage I cancers, resulting in a higher proportion of late-stage diagnoses.
BioPharma Drive: Drug Pricing
AUGUST 3, 2023
The company disclosed the study result alongside second quarter earnings showing Lumakras sales were flat versus the same period one year prior.
Drugs.com
AUGUST 3, 2023
THURSDAY, Aug. 3, 2023 -- New research shows that an experimental drug fine-tuned to a specific pain pathway can ease post-surgery aches, a finding that may eventually offer an alternative to highly addictive opioids. The pill, known for now as.
Drug Channels
AUGUST 1, 2023
In my most recent video webinar , I explored how plans and PBMs are turning to novel—and highly controversial—benefit design tools that access manufacturers’ patient support spending: copay accumulators, maximizers, and alternative funding programs. In the video excerpt below, I describe these new approaches that plans offset specialty drug expenses.
SCIENMAG: Medicine & Health
JULY 30, 2023
Research Highlights: A novel vaccine that targets a protein involved in Alzheimer’s disease helped eliminate toxic cells in mice with the condition. After vaccination, the mice had fewer amyloid plaques and less inflammation in brain tissue and showed improvement in behavior and awareness. Embargoed until 12 p.m. CT/1 p.m.
BioPharma Drive: Drug Pricing
AUGUST 3, 2023
Sales of the company’s COVID-19 vaccine plummeted 94% year over year. But executives believe newer products can help revenue rebound.
Drugs.com
AUGUST 1, 2023
TUESDAY, Aug. 1, 2023 -- One dose of the hallucinogenic ingredient in "magic mushrooms" may help some people with anorexia move past their preoccupation with body image, an early study suggests. The study, of just 10 women with anorexia, tested the.
Expert insights. Personalized for you.
98 
Let's personalize your content